As the SARS-CoV-2 testing shifts from a focus on identification of cases, to epidemiological and serological studies.  These studies will be looking at serological samples to determine

prevalence and immunity and will be vital for the development of drugs and vaccines.

The NEO® Sample Management System is ideally suited to this owing to the following features:

• Complete security and full traceability
• The refrigerator or freezer storage phase is fully monitored
• Guaranteed sample integrity
• Ability to share and centralize data
• Minimizes staff exposure to blood samples
• Efficient storage volumes (micro plates reduce space required by 4 to 6 fold)